Tagged Articles

The New York Times 2 articles

F.D.A. Weighs Penalties in Drug Recall

The Johnson & Johnson unit that recalled millions of bottles of liquid children's Tylenol and other pediatric medicines last month may face criminal penalties, product seizures or other sanctions, an official from the Food and Drug Administration said Thursday. The agency is considering further actions against McNeil Consumer Healthcare, the Johnson & Johnson unit, after a pattern of violations in manufacturing and quality control practices led to a number of recent recalls, Dr. Joshua M. Sharfstein, the F.D.A.'s principal deputy commissioner, said at a Congressional hearing on Thursday. ... Read More

Questions for Makers on Defects in Drugs

For consumers who turned to drugstore house brands after the recall last month of liquid children's Tylenol and other medicines made by a unit of Johnson & Johnson, there is yet more unsettling news. The recall included more than 40 varieties of liquid pediatric Tylenol, Motrin, Benadryl and Zyrtec that may have contained metal particles, too much of the active drug ingredient or inactive ingredients that did not meet testing requirements. At the time, the Food and Drug Administration recommended that consumers look for generic alternatives to these brand-name over-the-counter drugs. ... Read More